Licensing & Tech Transfer

Monetizing business assets.

Husch Blackwell negotiates global and regional licenses that drive revenues while allowing clients to retain ownership of intellectual property. We have licensed the development and use of novel compounds, human and animal drugs, medical devices, and biologics, as well as trademarks, trade secrets, and copyrights.

In developing comprehensive licensing strategies for emerging and larger technology companies, our attorneys take into account the unique business pressures each group faces. We also have significant experience helping clients divest assets they no longer wish to pursue.